Clinical Trials Directory

Trials / Unknown

UnknownNCT06246994

Predictors of Mortality Among Ventilator Associated Pneumonia Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
140 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In this context, this study aims to explore the risk factors for mortality from VAP in respiratory ICU.

Detailed description

Pneumonia is the most common infection treated within ICUs and carries significant mortality risk . Ventilator-associated pneumonia (VAP) is a specific form of nosocomial pneumonia occurring in patients greater than 48 hours after intubation and the initiation of mechanical ventilation . VAP is considered a leading cause of morbidity and mortality among intensive care unit infections. Despite various preventive measures, the incidence of VAP remains high . In studies, VAP-related mortality is 14-70% . It is contemplated that there are independent risk factors, increasing VAP-related mortality . However, the question of which factors are associated with early or late mortality in patients with VAP diagnosis, remains unanswered. Early identification and understanding of the etiology of VAP in the ICU is essential to prevent mortality and morbidity.

Conditions

Timeline

Start date
2024-03-01
Primary completion
2025-03-01
Completion
2025-09-01
First posted
2024-02-07
Last updated
2024-02-13

Source: ClinicalTrials.gov record NCT06246994. Inclusion in this directory is not an endorsement.